Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 7Phase 1 6Phase 1/2 3Phase EARLY_PHASE1 2Phase 4 2Phase 3 2Phase 2/3 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Neuroendocrine Tumors 7Thyroid Carcinoma, Anaplastic 3Thyroid Cancer, Papillary 3Neoplasms 3Multiple Endocrine Neoplasia Type 1 3Thyroid Neoplasms 2Somatostatinoma 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Multiple Myeloma 2Laryngeal Neoplasms 2Hematologic Neoplasms 2Glioma 2Gastroenteropancreatic Neuroendocrine Tumors 2Erdheim-Chester Disease 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adrenal Gland Neoplasms 2Adenoma, Islet Cell 2Vipoma 1Thyroid cancer, Hurthle cell 1Pituitary Neoplasms 1Pheochromocytoma 1Parathyroid Neoplasms 1Paraganglioma 1Muscle Weakness 1Motor Activity 1Melanoma 1

Interventions

Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Adrenal Gland Neoplasms × Endocrine × Clear all
NCT06100367 2025-12-02

11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

Changi General Hospital

Phase 2/3 Active not recruiting
100 enrolled
Endocrine

Adrenal Gland Neoplasms, Hyperaldosteronism, Neoplasm Metastasis

NCT00997594 2015-04-28

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Mie University

Phase 2/3 Completed
18 enrolled 6 charts
Endocrine

Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡